Protein Oxidation Mitigation Through Formulation Optimization
Protein oxidation can affect the quality and appearance of therapeutic protein products and may become an important formulation challenge during drug product development.
During the formulation development of a monoclonal antibody, the finished product was observed to develop a yellow color following light exposure. A targeted formulation investigation was conducted to identify the underlying cause and establish a suitable formulation strategy.
By screening appropriate buffer systems and antioxidants, the formulation was optimized to mitigate the observed color change associated with protein oxidation.
Development Challenge
During formulation development, the monoclonal antibody product exhibited yellowing after light exposure.
The key challenge was to determine the cause of the color change and identify a formulation approach that could effectively address the issue without delaying the overall development program.
The investigation focused on:
- Understanding the cause of light-induced yellowing
- Evaluating the potential role of protein oxidation
- Screening suitable buffer systems
- Evaluating appropriate antioxidants
- Identifying a formulation capable of improving product stability
Formulation Development Strategy
A targeted formulation development strategy was implemented to investigate the cause of light-induced yellowing and identify formulation conditions capable of mitigating protein oxidation. The study integrated root cause investigation with systematic screening of buffer systems and antioxidants to establish a suitable formulation for the monoclonal antibody.
Root Cause Investigation
The observed yellowing was investigated to determine its underlying cause and was associated with oxidation of the target protein.
Key Focus:
Light-Induced Yellowing
Protein Oxidation
Root Cause Analysis
Buffer System Screening
Suitable buffer systems were evaluated to identify formulation conditions that could support antibody stability and help mitigate oxidation-related changes.
Key Focus:
Buffer Selection
Formulation Stability
Protein Protection
Antioxidant Screening
Antioxidants were screened in combination with suitable formulation conditions to identify an effective approach for controlling oxidation-related product changes.
Key Focus:
Antioxidant Screening
Oxidation Mitigation
Product Stability
Formulation Optimization
The screening results were integrated to establish an optimized formulation strategy while supporting the overall drug product development timeline.
Key Focus:
Formulation Optimization
Quality Control
Development Continuity
Results
The formulation investigation successfully identified protein oxidation as the underlying cause of the light-induced yellowing observed during development.
Screening of buffer systems and antioxidants enabled the formulation to be optimized to address the oxidation-related product quality issue.
Formulation Issue Resolved Without Delaying Development
The investigation was completed rapidly enough that the formulation issue did not delay the overall process development program.
The project subsequently progressed successfully to pilot-scale manufacturing.
Key Outcomes
- Light-induced yellowing was investigated and attributed to protein oxidation
- Suitable buffer systems and antioxidants were screened
- An optimized formulation strategy was established
- The formulation development issue was resolved without delaying the overall development timeline
- The project successfully progressed to pilot-scale manufacturing
Project Outcome
This case demonstrates the importance of timely formulation investigation and optimization when unexpected product quality changes are identified during drug product development.
By combining root cause investigation with systematic buffer and antioxidant screening, the oxidation-related color change was addressed within the formulation development program. The rapid resolution of the issue allowed the project to proceed without disrupting the overall development schedule and successfully advance to pilot-scale manufacturing.
Related Services
